Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 101

1.

PACAP and VIP expression in the periaqueductal grey of the rat following sciatic nerve constriction injury.

Castorina A, Vogiatzis M, Kang JWM, Keay KA.

Neuropeptides. 2019 Apr;74:60-69. doi: 10.1016/j.npep.2018.12.002. Epub 2018 Dec 15.

PMID:
30579677
2.

Differential regulation of glucocorticoid receptor expression in distinct columns of periaqueductal grey in rats with behavioural disability following nerve injury.

Mor D, Keay KA.

Cell Mol Neurobiol. 2013 Oct;33(7):953-63. doi: 10.1007/s10571-013-9962-3. Epub 2013 Jul 12.

PMID:
23846420
3.

Anatomically specific patterns of glial activation in the periaqueductal gray of the sub-population of rats showing pain and disability following chronic constriction injury of the sciatic nerve.

Mor D, Bembrick AL, Austin PJ, Wyllie PM, Creber NJ, Denyer GS, Keay KA.

Neuroscience. 2010 Apr 14;166(4):1167-84. doi: 10.1016/j.neuroscience.2010.01.045. Epub 2010 Jan 28.

PMID:
20109535
4.

PACAP-38 but not VIP induces release of CGRP from trigeminal nucleus caudalis via a receptor distinct from the PAC1 receptor.

Jansen-Olesen I, Baun M, Amrutkar DV, Ramachandran R, Christophersen DV, Olesen J.

Neuropeptides. 2014 Apr;48(2):53-64. doi: 10.1016/j.npep.2014.01.004. Epub 2014 Jan 25.

PMID:
24508136
5.

Distribution of vasoactive intestinal peptide, pituitary adenylate cyclase-activating peptide, nitric oxide synthase, and their receptors in human and rat sphenopalatine ganglion.

Csati A, Tajti J, Kuris A, Tuka B, Edvinsson L, Warfvinge K.

Neuroscience. 2012 Jan 27;202:158-68. doi: 10.1016/j.neuroscience.2011.10.055. Epub 2011 Nov 7.

PMID:
22108610
6.

VPAC2-R mediates the lipolytic effects of pituitary adenylate cyclase-activating polypeptide/vasoactive intestinal polypeptide in primary rat adipocytes.

Akesson L, Ahrén B, Edgren G, Degerman E.

Endocrinology. 2005 Feb;146(2):744-50. Epub 2004 Oct 28.

PMID:
15514088
7.

Parabrachial Pituitary Adenylate Cyclase-Activating Polypeptide Activation of Amygdala Endosomal Extracellular Signal-Regulated Kinase Signaling Regulates the Emotional Component of Pain.

Missig G, Mei L, Vizzard MA, Braas KM, Waschek JA, Ressler KJ, Hammack SE, May V.

Biol Psychiatry. 2017 Apr 15;81(8):671-682. doi: 10.1016/j.biopsych.2016.08.025. Epub 2016 Aug 29.

8.
9.

The role of VIP/PACAP receptor subtypes in spinal somatosensory processing in rats with an experimental peripheral mononeuropathy.

Dickinson T, Mitchell R, Robberecht P, Fleetwood-Walker SM.

Neuropharmacology. 1999 Jan;38(1):167-80.

PMID:
10193908
10.

Expression of VPAC2 receptor and PAC1 receptor splice variants in the trigeminal ganglion of the adult rat.

Chaudhary P, Baumann TK.

Brain Res Mol Brain Res. 2002 Aug 15;104(2):137-42.

PMID:
12225867
11.

Impaired nocifensive behaviours and mechanical hyperalgesia, but enhanced thermal allodynia in pituitary adenylate cyclase-activating polypeptide deficient mice.

Sándor K, Kormos V, Botz B, Imreh A, Bölcskei K, Gaszner B, Markovics A, Szolcsányi J, Shintani N, Hashimoto H, Baba A, Reglodi D, Helyes Z.

Neuropeptides. 2010 Oct;44(5):363-71. doi: 10.1016/j.npep.2010.06.004.

PMID:
20621353
13.

Pituitary adenylate cyclase-activating polypeptide and PACAP receptor expression and function in the rat adrenal gland.

Mazzocchi G, Malendowicz LK, Neri G, Andreis PG, Ziolkowska A, Gottardo L, Nowak KW, Nussdorfer GG.

Int J Mol Med. 2002 Mar;9(3):233-43.

PMID:
11836629
14.
15.

Pharmacology and functions of receptors for vasoactive intestinal peptide and pituitary adenylate cyclase-activating polypeptide: IUPHAR review 1.

Harmar AJ, Fahrenkrug J, Gozes I, Laburthe M, May V, Pisegna JR, Vaudry D, Vaudry H, Waschek JA, Said SI.

Br J Pharmacol. 2012 May;166(1):4-17. doi: 10.1111/j.1476-5381.2012.01871.x. Review.

16.

Evidence for cellular injury in the midbrain of rats following chronic constriction injury of the sciatic nerve.

Mor D, Bembrick AL, Austin PJ, Keay KA.

J Chem Neuroanat. 2011 Apr;41(3):158-69. doi: 10.1016/j.jchemneu.2011.01.004. Epub 2011 Feb 1.

PMID:
21291996
17.

Pituitary adenylate cyclase-activating polypeptide, vasoactive intestinal polypeptide and their receptors: distribution and involvement in the secretion of Podarcis sicula adrenal gland.

Valiante S, Prisco M, Sciarrillo R, De Falco M, Capaldo A, Gay F, Andreuccetti P, Laforgia V, Varano L.

J Endocrinol. 2008 Feb;196(2):291-303. doi: 10.1677/JOE-07-0127.

PMID:
18252952
18.

Expression and function of vasoactive intestinal peptide, pituitary adenylate cyclase-activating polypeptide, and their receptors in the human adrenal gland.

Mazzocchi G, Malendowicz LK, Rebuffat P, Gottardo L, Nussdorfer GG.

J Clin Endocrinol Metab. 2002 Jun;87(6):2575-80.

PMID:
12050216
19.

Expression of pituitary adenylate cyclase-activating polypeptide in dorsal root ganglia following axotomy: time course and coexistence.

Zhang Q, Shi TJ, Ji RR, Zhang YZ, Sundler F, Hannibal J, Fahrenkrug J, Hökfelt T.

Brain Res. 1995 Dec 24;705(1-2):149-58. Erratum in: Brain Res 1997 Jan 16;745(1-2):357. Zhang Y [corrected to Zhang YZ].

PMID:
8821745
20.

VIP, PACAP-38, BDNF and ADNP in NMDA-induced excitotoxicity in the rat retina.

Teuchner B, Dimmer A, Humpel C, Amberger A, Fischer-Colbrie R, Nemeth J, Waschek JA, Kieselbach G, Kralinger M, Schmid E, Bechrakis N, Troger J.

Acta Ophthalmol. 2011 Nov;89(7):670-5. doi: 10.1111/j.1755-3768.2009.01828.x. Epub 2010 Jan 8.

Supplemental Content

Support Center